Sorry Chazz… wasn’t meant to bring up old wounds. I rode the stock up and back down and lost all interest in watching it for a couple of years. Never sold a share to my issue also I feel for us all. Holding out and for the next big thing to happen. It’s been a rough road for CYDY.

I feel it like you do but to see a possible even 3-5 indications of big markets like MASH to what is still NASH to me. How a dollar value keeps the excitement of Leronlimab for probably not just me but others. I don’t see it as a bad thing. I am an optimist at heart. I hope just like everybody else we get one indication across the line but there is a lot of direction to go with Leronlimab.

Speculation just makes it more exciting and this could be the year we make big progress. Let’s hope anyway. I love that HIV cure is maybe close and maybe us. That cancer is the highest on our list. That there’s other indications that could pop in time. I also realize we can be bought out or maybe partnered. With multiple indications… I do prefer partners for the 1st or even two indications. But being bought out is not the best way but still good. I am a realist is some respects. I was just looking for something that might have been put forward by someone on the board. To understand a value… is a good thing to me.